Tech Talk: Israeli firm wins landmark FDA clearance for injection-based diabetes app

Posted Monday, September 28, 2026 1:00 pm

Via The Jerusalem Post

Petah Tikva-based DreaMed Diabetes has just received FDA 510(k) clearance for MODI, a prescription medical application that automatically optimizes insulin dosing for adults with type 2 diabetes.

Continue reading at The Jerusalem Post »

Submit News

E-edition

October 2026

View this issue

Browse other issues

Upcoming events

Jewish holidays

Tomorrow | Shmini Atzeret,

Tomorrow | Temple Sinai Festival Breakfast,

Every Saturday, starting September 19 - October 3 | Temple Sinai Torah Study,

Every Saturday, starting September 26 - October 3 | Temple Sinai Morning Service,

Jewish holidays

Sunday | Simchat Torah,

Camp JORI: New solar array generates savings, cuts CO2 emissions

After a decade of hoping and planning, Camp JORI in South Kingstown finally dedicated its new solar array, which promises tens of thousands of dollars in savings each year and a big reduction in the camp's environmental footprint.

Tech Talk: Israeli firm wins landmark FDA clearance for injection-based diabetes app

about jewish rhode island

adding your voice

published by